| Home page | News | About us | Investment | Contact us | 
Position: China Medical City >> News >> Major CMC News >> The text

High-level Forum of …

Project of Taizhou I…

China Medical City C…

Delegation from the …
[Article with image]Industrialization of Four National New Category 1 Drugs takes place in CMC           ★★★
Industrialization of Four National New Category 1 Drugs takes place in CMC

Author:CMC Article source:CMC Click the number:478 Update time:2018-7-24 22:19:37


On July 24, CMC and Taizhou Edding Jing'ang Pharmaceutical Co., Ltd. held a signing ceremony for a drug R&D and industrialization project. Edding Jing'ang Pharmaceutical will industrialize four national new Category 1 drugs in CMC, all of which have obtained the Clinical Drug Trial Approval.
Taizhou Edding Jing'ang Pharmaceutical focuses on the introduction, clinical R&D, production and sales of new cancer drugs. The company currently owns 5 national innovative Category 1 drugs, and 4 of them have obtained clinical approval. The company ranks among China's top 100 enterprises in terms of comprehensive drug R&D capability in 2018.

NewsInputer:CMC    Editor:CMC 
  • Back ArticleNews:

  • Next ArticleNews:
  • 【Typeface:Small Big】【Comment】【Add favorite】【Mail this page】【Print】【Close
      The netizen comments:(Show only the latest 10. Review the content of view, has nothing to do with the stand!)

    | Set home | Add to Favorites | Contact the webmaster | About us |
    Copyright © 2014 Medmax.cn Inc. All rights reserved. Medmax.cn
    The competent units:Taizhou National Medical High-tech Development Zone
    Copyright: Taizhou pharmaceutical hi tech Industrial Park Management Committee
    苏ICP备14026810号-1 苏B2-20070164